The new treatment involves administering a single injection of adult donor bone marrow stem cells into a patient’s degenerative disc. The technology could regenerate the deteriorating intervertebral disc and reverse damage to the spine.
Mesoblast, a global medical device company, will sponsor the trial.
Related Articles on Pain Management:
Opioid Pain Reliever Overdose Kills More Than Heroin and Cocaine Combined
Oregon’s High Rate of Pain Drug Abuse Linked to Heavy Prescribing
Opioid Abuse Increasing in Older White Women
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
